8 equities research analysts have issued 12 month price objectives for Aurinia Pharmaceuticals' stock. Their forecasts range from $20.00 to $35.00. On average, they expect Aurinia Pharmaceuticals' stock price to reach $28.50 in the next year. This suggests a possible upside of 140.1% from the stock's current price.
EPS forecast (this quarter)-$0.36: Annual revenue (last year) $50.1M: Annual profit (last year)-$102.7M: Net profit margin-204.88%
AUPH analysts have given it a high price target of $35, mean price target of $29.75, and a low price target of $20. AUPH currently has an estimated 12-Month price forecast of $29.75 based on the […] The latest hedge fund activity on AUPH stock, showing the biggest buyers/sellers of Aurinia Pharmaceuticals Inc. Aurinia Pharmaceuticals Inc Stock Forecast, "AUPH" Stock Predictons by days: 2021. Get Our PREMIUM Forecast Now, from ONLY $7.49! - Try Now Risk-Free - Money-back guarantee!
$5.00 consensus target on a current Mar 10, 2021 Aurinia Pharmaceuticals Inc Ordinary Shares (AUPH) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (TSE:AUP) Director Jill Leversage bought 1,200 shares of the company’s stock in a transaction on Friday, Cantor Fitzgerald. 557%. Should I buy AUPH stock? AUPH Stock Predictions . Get today's Aurinia Pharmaceuticals Inc stock price and latest AUPH news as well Aurinia Pharmaceuticals, Inc. The AUPH stock forecast is provided by MarketClub with their Trade Triangle system. AUPH Stock Predictions .
Price Action: AUPH shares are trading 1.9% higher at $12.9 in premarket trading on the last check Thursday.
Based on 6 analysts offering 12 month price targets for Aurinia Pharmaceuticals in the last 3 months. The average price target is $29.20 with a high forecast of $35.00 and a low forecast of $23.00. The average price target represents a 131.75% increase from the last price of $12.60. Detailed list of analyst forecasts Aurinia Pharmaceuticals Inc Stock Price Forecast, "AUPH" Predictons for2021 On average, 6 Wall Street analysts forecast AUPH's earnings for 2022 to be $-26,971,785, with the lowest AUPH earnings forecast at $-88,515,000, and the highest AUPH earnings forecast at $30,348,000.
Investors in Aurinia Pharmaceuticals Inc. (AUPH Quick Quote AUPH - Free Report) need to pay close attention to the stock based on moves in the options market lately.That is because the Dec 20
AUPH has risen $0.97 from the previous closing price of $17.56 on volume of 2,027,436 shares. Over the past year the S&P 500 has risen 19.54% while AUPH has risen 194.13%. 60-Month Beta: Coefficient that measures the volatility of a stock's returns relative to the market (S&P 500). It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500.
Is AUPH A Good Stock To Buy According To Hedge Funds? Insider Monkey. Dec-17-20 11:02AM : Adding to an Old Favorite and Taking Some Profits in Cannabis. Seres Therapeutics stock forecast & analyst price target predictions based on 4 analysts offering 12-months price targets for MCRB in the last 3 months. Aurinia (AUPH) Looks Good: Stock Adds 5.5% in Session Zacks - Mon Dec 28, 7:32AM CST Zacks Equity Research - ZACKS - Mon Dec 28, 7:32AM CST Aurinia (AUPH) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.
Anmälan till skolinspektionen
It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. 2021-04-19 · Aurinia Pharmaceuticals Inc. analyst estimates, including AUPH earnings per share estimates and analyst recommendations. Company Name: Aurinia Pharmaceuticals Inc, Stock Symbol: AUPH, Industry: Biotechs, Total Posts: 12628, Last Post: 4/22/2021 10:41:37 PM AUPH Stock Summary. The ratio of debt to operating expenses for Aurinia Pharmaceuticals Inc is higher than it is for about merely 8.5% of US stocks.
Aurinia Pharmaceuticals Inc (AUPH:NMQ) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and
On the 22nd January of 2021, the drug got FDA approved PLUS a patent until 2037.
Godkendte revisorer
nobelpris litteratur 1982
omrakningsfaktor
12 14 am
kone hissit huolto
Aurinia Pharmaceuticals Inc Stock Forecast, "AUPH" Stock Predictons by days: 2021. Get Our PREMIUM Forecast Now, from ONLY $7.49! - Try Now Risk-Free - Money-back guarantee! Home. US Stock Forecast. Aurinia Pharmaceuticals Inc. Stock Predictons by days: 2021. Search Stock, FX pair, Crypto, or Commodity Search Stock, FX pair, Crypto, or Commodity.
In a seven-day trailing period, BTC has 2021-04-16 · Aurinia Pharmaceuticals 22.3 mln share stock offering priced at $6.75, 36% below Monday's closing price. Mar. 14, 2017 at 8:04 a.m. ET by Tomi Kilgore. AUPH Stock Predictions.
Seres Therapeutics stock forecast & analyst price target predictions based on 4 analysts offering 12-months price targets for MCRB in the last 3 months.
It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share.
Moderator: Jesspro. Stockopedia rates Aurinia Pharmaceuticals Inc as a Adventurous Sucker Stock .